Neurology Central

NS1-based Zika vaccine demonstrates promise in mice

Research presented at the American Society for Microbiology Microbe 2017 conference (1–5 June, LA, USA) has reported a novel Zika vaccine, which can induce 100% protection in mice after a single dose. This is the first vaccine to be based on the Zika virus non-structural protein 1 (NS1).
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.